Michele Cavo MD

Michele Cavo, MD, is a Full Professor of Haematology at the University of Bologna, Faculty of Medicine and Surgery, Bologna, Italy, and Head of the “Seràgnoli” Institute of Haematology in Bologna. He received his medical degree cum laude from the University of Bologna, where he was also awarded his postgraduate degree in haematology. In 1991 he became Assistant Professor of Haematology, and in 1998 he was appointed Professor of Haematology at Bologna University School of Medicine.

From January 2000 to June 2005 and from April 2017 to date Professor Cavo has served as Director of Postgraduate Residency in Haematology at the University School of Medicine in Bologna. He was a member of the board of the Italian Society of Haematology from 2004 to 2009 and from 2017 to date and has served as Treasurer of the Society. He is also co-Chair of the Italian Myeloma Network GIMEMA. The main research interests of Professor Cavo focus on multiple myeloma and plasma cell dyscrasias.

Professor Cavo has been the Principal Investigator of many academic phase III Italian and European studies for newly diagnosed myeloma patients and has authored many papers published in peer-reviewed journals, including the New England Journal of Medicine, the Lancet, the Lancet Oncology, The Lancet Haematology, Blood, the Journal of Clinical Oncology, Leukemia, British Journal of Haematology, Haematologica, and others. He has been a member of the Editorial Board of the Journal of Clinical Oncology and Haematologica.